Hollsteen
← Zoom

Cash and equivalents

Balance – as of period end · $M

QuartersFiscal years

$MCash and equivalents · Q1 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Cash and equivalents · Q2 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Cash and equivalents · Q3 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Cash and equivalents · Q4 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Cash and equivalents · Q1 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Cash and equivalents · Q2 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Cash and equivalents · Q3 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Cash and equivalents · Q4 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Cash and equivalents · Q1 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Cash and equivalents · Q2 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Cash and equivalents · Q3 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Cash and equivalents · Q4 FY2018: $36.0M · 10-K 0001585521-20-000095 filed Mar 20, 2020Cash and equivalents · Q1 FY2019: $31.0M · 10-Q 0001564590-19-022032 filed Jun 7, 2019Cash and equivalents · Q2 FY2019: $36.0M · 10-Q 0001585521-19-000020 filed Sep 13, 2019Cash and equivalents · Q3 FY2019: $64.0M · 10-Q 0001585521-19-000059 filed Dec 9, 2019Cash and equivalents · Q4 FY2019: $64.0M · 10-K 0001585521-20-000095 filed Mar 20, 2020Cash and equivalents · Q1 FY2020: $630M · 10-Q 0001564590-19-022032 filed Jun 7, 2019Cash and equivalents · Q2 FY2020: $214M · 10-Q 0001585521-19-000020 filed Sep 13, 2019Cash and equivalents · Q3 FY2020: $231M · 10-Q 0001585521-19-000059 filed Dec 9, 2019Cash and equivalents · Q4 FY2020: $283M · 10-K 0001585521-20-000095 filed Mar 20, 2020Cash and equivalents · Q1 FY2021: $489M · 10-Q 0001585521-20-000154 filed Jun 5, 2020Cash and equivalents · Q2 FY2021: $749M · 10-Q 0001585521-20-000238 filed Sep 3, 2020Cash and equivalents · Q3 FY2021: $731M · 10-Q 0001585521-20-000299 filed Dec 4, 2020Cash and equivalents · Q4 FY2021: $2.2B · 10-K 0001585521-21-000048 filed Mar 18, 2021Cash and equivalents · Q1 FY2022: $1.6B · 10-Q 0001585521-21-000131 filed Jun 2, 2021Cash and equivalents · Q2 FY2022: $1.9B · 10-Q 0001585521-21-000235 filed Aug 31, 2021Cash and equivalents · Q3 FY2022: $1.3B · 10-Q 0001585521-21-000295 filed Nov 23, 2021Cash and equivalents · Q4 FY2022: $1.1B · 10-K 0001585521-22-000037 filed Mar 7, 2022Cash and equivalents · Q1 FY2023: $1.4B · 10-Q 0001585521-22-000106 filed May 25, 2022Cash and equivalents · Q2 FY2023: $937M · 10-Q 0001585521-22-000180 filed Aug 24, 2022Cash and equivalents · Q3 FY2023: $1.1B · 10-Q 0001585521-22-000213 filed Nov 23, 2022Cash and equivalents · Q4 FY2023: $1.1B · 10-K 0001585521-23-000035 filed Mar 3, 2023Cash and equivalents · Q1 FY2024: $1.0B · 10-Q 0001585521-23-000128 filed May 25, 2023Cash and equivalents · Q2 FY2024: $1.4B · 10-Q 0001585521-23-000194 filed Aug 23, 2023Cash and equivalents · Q3 FY2024: $1.5B · 10-Q 0001585521-23-000249 filed Nov 21, 2023Cash and equivalents · Q4 FY2024: $1.6B · 10-K 0001585521-24-000030 filed Mar 4, 2024Cash and equivalents · Q1 FY2025: $1.9B · 10-Q 0001585521-24-000094 filed May 22, 2024Cash and equivalents · Q2 FY2025: $1.5B · 10-Q 0001585521-24-000181 filed Aug 23, 2024Cash and equivalents · Q3 FY2025: $1.3B · 10-Q 0001585521-24-000260 filed Nov 26, 2024Cash and equivalents · Q4 FY2025: $1.3B · 10-K 0001585521-25-000042 filed Feb 28, 2025Cash and equivalents · Q1 FY2026: $1.2B · 10-Q 0001585521-25-000090 filed May 23, 2025Cash and equivalents · Q2 FY2026: $1.2B · 10-Q 0001585521-25-000141 filed Aug 22, 2025Cash and equivalents · Q3 FY2026: $1.2B · 10-Q 0001585521-25-000202 filed Nov 25, 2025Cash and equivalents · Q4 FY2026: $1.3B · 10-K 0001585521-26-000030 filed Feb 27, 2026Cash and equivalents · Q1 FY2027: $891M · 10-Q 0001585521-26-000071 filed May 22, 2026Cash and equivalents · Q2 FY2027: $932M · 10-Q 0001585521-26-000121 filed Aug 26, 2026missing1,380932362,240Q1 FY2016Q2 FY2027Q2 FY2024
$MCash and equivalents · Q2 FY2023: $937M · 10-Q 0001585521-22-000180 filed Aug 24, 2022Cash and equivalents · Q3 FY2023: $1.1B · 10-Q 0001585521-22-000213 filed Nov 23, 2022Cash and equivalents · Q4 FY2023: $1.1B · 10-K 0001585521-23-000035 filed Mar 3, 2023Cash and equivalents · Q1 FY2024: $1.0B · 10-Q 0001585521-23-000128 filed May 25, 2023Cash and equivalents · Q2 FY2024: $1.4B · 10-Q 0001585521-23-000194 filed Aug 23, 2023Cash and equivalents · Q3 FY2024: $1.5B · 10-Q 0001585521-23-000249 filed Nov 21, 2023Cash and equivalents · Q4 FY2024: $1.6B · 10-K 0001585521-24-000030 filed Mar 4, 2024Cash and equivalents · Q1 FY2025: $1.9B · 10-Q 0001585521-24-000094 filed May 22, 20241,3801,886937Q2 FY2023Q1 FY2025Q2 FY2024
Q2 FY2024
1,380$M
All values (35)
PeriodValue ($M)Status
Q2 FY2027932reported
Q1 FY2027891reported
Q4 FY20261,273reported
Q3 FY20261,216reported
Q2 FY20261,199reported
Q1 FY20261,229reported
Q4 FY20251,349reported
Q3 FY20251,274reported
Q2 FY20251,539reported
Q1 FY20251,886reported
Q4 FY20241,558reported
Q3 FY20241,493reported
Q2 FY20241,380reported
Q1 FY20241,030reported
Q4 FY20231,087reported
Q3 FY20231,096reported
Q2 FY2023937reported
Q1 FY20231,407reported
Q4 FY20221,063reported
Q3 FY20221,322reported
Q2 FY20221,931reported
Q1 FY20221,557reported
Q4 FY20212,240reported
Q3 FY2021731reported
Q2 FY2021749reported
Q1 FY2021489reported
Q4 FY2020283reported
Q3 FY2020231reported
Q2 FY2020214reported
Q1 FY2020630reported
Q4 FY201964reported
Q3 FY201964reported
Q2 FY201936reported
Q1 FY201931reported
Q4 FY2018Noneerror

11 periods without value hidden · Show gaps with reason · CSV with all sources · Technical ID: cash

More metrics for Zoom

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$1.4B
Period
Q2 FY2024, ended Jul 31, 2023 · as of Jul 31, 2023 (balance as of date, not a sum)
Source
10-Q, filed Aug 23, 2023 · 0001585521-23-000194
Location
us-gaap:CashAndCashEquivalentsAtCarryingValue
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$1.4BAug 23, 202310-Q 0001585521-23-000194reported · confidence 1. · current